Are Pharmaceutical Patents a Barrier to Access to Medicines?
Critics argue that pharmaceutical patents are a barrier to wide-reaching access to medicines, especially for vulnerable populations in the developing world. They cast their argument in the phrase, "patents kill" and advocate against intellectual property protection for medical innovation and the trade agreements that incorporate them. Their position, however, begs the question of what truly influences a population's access to medicines.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063